CDC: HIV Prevention Pill Underutilized in NC, Minorities at Risk

Why it matters locally: The CDC's report on PrEP underutilization is highly relevant to North Carolina, particularly concerning the health and well-being of minority communities across the state. Given North Carolina's significant population of over 10 million, and knowing that HIV disproportionately impacts minority groups, any disparities in access to preventative medication like PrEP could have serious consequences for public health outcomes statewide. Increased awareness campaigns and targeted outreach programs may be necessary to ensure equitable access to PrEP, potentially reducing rates of new HIV infections, especially among the Black/African American and Hispanic/Latino populations in NC.

---

Denver, CO - A new analysis released by the Centers for Disease Control and Prevention (CDC) indicates that pre-exposure prophylaxis (PrEP), a medication used to prevent HIV infection, is not being utilized by a significant portion of the at-risk population in the United States. The findings were presented at the 2018 Conference on Retroviruses and Opportunistic Infections. The CDC analysis highlights that disparities exist in PrEP access and uptake, with people of color being disproportionately affected. Data suggests that a considerable number of individuals who could benefit from PrEP are not receiving or utilizing the medication. Further details regarding the specific methodology of the CDC analysis, the size and demographics of the study population, and specific data points on PrEP usage rates were not immediately available. Further information is expected to be released by the CDC in the near future.